$NCSM

DEANE JOHN D sold (to issuer) 10,731 shares of NCSM (indirect holdings)

DEANE JOHN D sold (to issuer) 10,731 indirectly-held shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · DEANE JOHN D
Published Sep 1, 2026, 1:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
high confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The transaction is routine and unlikely to affect market perception of NCSM.

02

Market read

Low relevance; typical insider sell with minimal market impact.

03

What to watch

Potential upcoming secondary offering or dilution could contextualize the sale.

Relevance 4/10Novelty 4/10Timing: same day filing

Background

Form 4 filings disclose insider transactions; this filing reports a director's sale of shares.

Company-level read

Ticker impact

$NCSMNeutralHigh confidence
Context

Director Deane John D sold 10,731 shares of NCS Multistage Holdings in a Form 4 filing.

Expected impact

No significant impact expected.

Evidence & confidence

The sale size is small relative to float and no price disclosed; typical routine insider transaction.

Market effects

None; transaction is company‑specific.

None; limited to NCSM shareholders.

None

Counterpoint

Even small insider sales can signal concerns, but without price data the signal is weak.

Key entities

  • NCS Multistage Holdings, Inc.

    US‑listed biotech firm (ticker NCSM).

  • Deane John D

    Director of NCSM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles